Effects of Probiotics on Metabolic Syndrome ,Intestinal Microflora and SCFA.

Clinical trial NCT06183801 · COMPLETED

Trial details

NCT number: NCT06183801
Sponsor: Glac Biotech Co., Ltd
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Metabolic Syndrome

Start date: 2021-08-01
Primary completion: 2022-09-30
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.